a public good project by the
Synthesis
Company
of California

© 2026

Suzy A. Griffin | doi.page

0 works0 citations0 h-index

Suzy A. Griffin

University of North Texas(US)University of North Texas Health Science Center(US)

Publications by Year

Research Areas

Receptor Mechanisms and Signaling, Neurotransmitter Receptor Influence on Behavior, Neuropeptides and Animal Physiology, Pharmacological Receptor Mechanisms and Effects, Neuroscience and Neuropharmacology Research

Most-Cited Works

→ N-(3-Fluoro-4-(4-(2-methoxy or 2,3-dichlorophenyl)piperazine-1-yl)butyl)arylcarboxamides as Selective Dopamine D3 Receptor Ligands: Critical Role of the Carboxamide Linker for D3 Receptor Selectivity(2011)69 cited
→ The Tetrahydroisoquinoline Derivative SB269,652 Is an Allosteric Antagonist at Dopamine D3 and D2 Receptors(2010)62 cited
→ Immunoblot and immunohistochemical comparison of murine monoclonal antibodies specific for the rat D1a and D1b dopamine receptor subtypes(1999)57 cited
→ Evaluation of D2 and D3 dopamine receptor selective compounds on l-dopa-dependent abnormal involuntary movements in rats(2009)52 cited
→ Evaluation of the D3 dopamine receptor selective antagonist PG01037 on l-dopa-dependent abnormal involuntary movements in rats(2009)44 cited
→ Highly Selective Dopamine D₃ Receptor Antagonists with Arylated Diazaspiro Alkane Cores(2017)36 cited

→ Comparison of the Binding and Functional Properties of Two Structurally Different D2 Dopamine Receptor Subtype Selective Compounds(2012)28 cited

→ Analogues of Arylamide Phenylpiperazine Ligands To Investigate the Factors Influencing D3 Dopamine Receptor Bitropic Binding and Receptor Subtype Selectivity(2018)27 cited

→ Design, synthesis, and evaluation of N-(4-(4-phenyl piperazin-1-yl)butyl)-4-(thiophen-3-yl)benzamides as selective dopamine D3 receptor ligands(2019)25 cited

→ Typical antipsychotics exhibit inverse agonist activity at rat dopamine D1-like receptors expressed in Sf9 cells(2001)23 cited